Press Releases
Strategies for Simplifying Biopharma's Digital Journey
The biopharma industry requires digital transformations to improve efficiencies and deliver critical therapeutics to patients at an accelerated rate. Although great efforts have gone into implementing data-driven business models and processes, the industry has seen mixed results in return, with the digital evolution remaining in the early phases of development.
Lack of standards, vision and appropriate strategies keep digitalisation programs from success, possibly preventing biopharma from achieving its goals for a data-driven future. Clearly, biopharma needs a shared vision and strategic roadmap to facilitate this transformation.
In this article, Samsung Biologics’ Chief Information and Marketing Officer, Process Improvement, James Choi delves into the shared vision of biopharma’s leaders to drive a digital transformation in their organisations. He also emphasizes the need for the industry to prepare for the road ahead.
Read more
The biopharma industry requires digital transformations to improve efficiencies and deliver critical therapeutics to patients at an accelerated rate. Although great efforts have gone into implementing data-driven business models and processes, the industry has seen mixed results in return, with the digital evolution remaining in the early phases of development.
Lack of standards, vision and appropriate strategies keep digitalisation programs from success, possibly preventing biopharma from achieving its goals for a data-driven future. Clearly, biopharma needs a shared vision and strategic roadmap to facilitate this transformation.
In this article, Samsung Biologics’ Chief Information and Marketing Officer, Process Improvement, James Choi delves into the shared vision of biopharma’s leaders to drive a digital transformation in their organisations. He also emphasizes the need for the industry to prepare for the road ahead.
Read more